Epogen Related Clinical Trials
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa [Completed]
Comparison Among Erythropoietin Stimulating Agents [Completed]
A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin [Completed]
A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin [Completed]
An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease [Completed]
Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia [Withdrawn]
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS [Completed]
Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa [Terminated]
HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD) [Completed]
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy [Completed]
Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study) [Not yet recruiting]
Efficacy Study of Epoetin Alfa in Friedreich Ataxia [Completed]
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery [Active, not recruiting]
Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy [Completed]
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients [Terminated]
The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery [Terminated]
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis [Terminated]
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy [Terminated]
A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities. [Completed]
Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery [Not yet recruiting]
Optimized Erythropoietin (EPO) Treatment [Recruiting]
A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment [Completed]
Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery [Completed]
Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis [Completed]
Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia [Completed]
Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations [Withdrawn]
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects. [Not yet recruiting]
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects [Not yet recruiting]
A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa [Completed]
Epoetin Alfa for HIV-Associated Neuropathy Trial [Withdrawn]
PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients [Completed]
Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients [Recruiting]
Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal Failure [Completed]
PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects [Not yet recruiting]
PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects. [Not yet recruiting]
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy [Terminated]
A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin [Completed]
A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin [Completed]
A Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis [Recruiting]
Treatment With Erythropoietin and Cognition During Hypoglycaemia [Completed]
Clinical Study to Examine the Effects of Erythropoietin on Left Ventricular Function After Acute Myocardial Infarction [Completed]
Efficacy Study of Two Formulations of Erythropoietin [Completed]
Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder [Completed]
A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies [Withdrawn]
Study to Evaluate the Efficacy and Safety of HX 575 vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients [Completed]
Renal Effects of Erythropoietin in Humans [Completed]
Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human [Recruiting]
Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD) [Terminated]
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2) [Completed]
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia [Completed]
Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI [Not yet recruiting]
Erythropoietin Therapy for Children With Cerebral Palsy [Not yet recruiting]
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer [Completed]
Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant [Completed]
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes [Active, not recruiting]
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) [Active, not recruiting]
Trial of Peg-Interferon Plus Epoetin-Alfa for Treatment of Chronic Hepatitis C Virus Infection [Completed]
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants [Completed]
Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery [Enrolling by invitation]
Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury [Completed]
Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia [Recruiting]
Erythropoietin in Traumatic Brain Injury (EPO-TBI) [Completed]
Dynepo Long-Term Safety Study [Terminated]
Erythropoietin in the Prevention of Acute Mountain Sickness [Completed]
An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes [Active, not recruiting]
Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial [Completed]
Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients [Terminated]
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [Terminated]
Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity [Completed]
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome. [Recruiting]
Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2) [Completed]
Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery [Completed]
Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia [Completed]
Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v. [Completed]
Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia [Completed]
Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP) [Withdrawn]
REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial [Terminated]
Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin [Completed]
Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy [Completed]
Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients [Completed]
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia [Recruiting]
Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement [Recruiting]
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia [Completed]
Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients [Not yet recruiting]
A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery. [Completed]
Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial [Recruiting]
Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS) [Completed]
A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia [Completed]
Safety Study of Erythropoietin (EPO) in Parkinson's Disease [Completed]
Erythropoietin and Platelet Activation Markers [Completed]
Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation [Terminated]
Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1 [Completed]
A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia [Completed]
Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis [Completed]
A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease [Completed]
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction [Completed]
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy [Active, not recruiting]
|
